Welcome to another episode of 'The Functional Code' with Dr. Addy and Dr. Jace. This episode dives deep into GLP-1 agonists, covering their role in weight loss and improving metabolic health. We discuss the popular GLP-1 medications like Semaglutide (Ozempic) and emerging compounds such as Tirzepatide and Reta. Learn about their mechanisms, benefits, and the challenges faced with pharmaceutical companies. We also touch on the importance of integrating healthy habits and proper medical supervision when using these medications for long-term success. Tune in for a comprehensive discussion on the future of GLP-1 agonists in healthcare.Episode 93Dr. Jace Nybo D.C.Dr. Addy Knutson D.C.Guide:00:00 Introduction to the Episode00:39 Understanding GLP-1 Agonists01:13 The Rise of Semaglutide01:22 Challenges with Peptide Medications03:11 Mechanisms of GLP-1 Agonists05:30 Comparing GLP-1 Agonists09:29 The Role of Lifestyle Changes15:31 Emerging Triple Agonists18:04 Future of GLP-1 Agonists20:25 Excitement for New Treatments20:33 History of GLP-1 Research21:14 Challenges in Patient Management21:47 Importance of Integrated Care22:45 Concerns About Long-Term Effects25:19 Oral GLP-1 Options27:48 Future of Multi-Agonist Treatments29:55 Hacking Physiology and Psychology30:53 Consistency in Fitness and Health35:12 Final Thoughts and ReferencesLong-Form:-New Weight Loss Strategies with GLP 1https://youtu.be/beu59bfiuKgResources: DOI: 10.1056/NEJMoa1603827DOI: 10.1056/NEJMoa2302392DOI: 10.1056/NEJMoa1411892DOI: 10.1056/NEJMoa2301972DOI: 10.1056/NEJMoa2416394DOI: 10.1056/NEJMoa2206038DOI: 10.1056/NEJMoa2032183DOI: 10.1056/NEJMoa2307563DOI: 10.1016/S0140-6736(19)31149-3DOI: 10.1016/S0140-6736(23)01302-8

Ver todos los episodios